These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 35639578)
1. The characterization of Morris DE; Osman KL; Cleary DW; Clarke SC Microb Genom; 2022 May; 8(5):. PubMed ID: 35639578 [No Abstract] [Full Text] [Related]
2. Age-related genotypic and phenotypic differences in Moraxella catarrhalis isolates from children and adults presenting with respiratory disease in 2001-2002. Verhaegh SJC; Streefland A; Dewnarain JK; Farrell DJ; van Belkum A; Hays JP Microbiology (Reading); 2008 Apr; 154(Pt 4):1178-1184. PubMed ID: 18375810 [TBL] [Abstract][Full Text] [Related]
3. Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infection. Ruckdeschel EA; Kirkham C; Lesse AJ; Hu Z; Murphy TF Infect Immun; 2008 Apr; 76(4):1599-607. PubMed ID: 18227159 [TBL] [Abstract][Full Text] [Related]
4. Serum antibody response to Moraxella catarrhalis proteins OMP CD, OppA, Msp22, Hag, and PilA2 after nasopharyngeal colonization and acute otitis media in children. Ren D; Almudevar AL; Murphy TF; Lafontaine ER; Campagnari AA; Luke-Marshall N; Casey JR; Pichichero ME Vaccine; 2015 Oct; 33(43):5809-5814. PubMed ID: 26392013 [TBL] [Abstract][Full Text] [Related]
5. Virulence determinants of Moraxella catarrhalis: distribution and considerations for vaccine development. Blakeway LV; Tan A; Peak IRA; Seib KL Microbiology (Reading); 2017 Oct; 163(10):1371-1384. PubMed ID: 28893369 [TBL] [Abstract][Full Text] [Related]
6. Microbiologic and virulence characteristics of Moraxella catarrhalis isolates from Zambian children presenting with acute pneumonia. Nawa M; Mwansa J; Mwaba J; Kaonga P; Mukubesa AN; Simuyandi M; Chisenga CC; Alabi P; Mwananyanda L; Thea DM; Chilengi R; Kwenda G Pediatr Pulmonol; 2022 Dec; 57(12):3084-3093. PubMed ID: 36056795 [TBL] [Abstract][Full Text] [Related]
7. Genotypic and Phenotypic Characteristics of Zhao N; Ren H; Deng J; Du Y; Li Q; Zhou P; Zhou H; Jiang X; Qin T Pathogens; 2022 Aug; 11(9):. PubMed ID: 36145417 [No Abstract] [Full Text] [Related]
8. Persistence of Moraxella catarrhalis in Chronic Obstructive Pulmonary Disease and Regulation of the Hag/MID Adhesin. Murphy TF; Brauer AL; Pettigrew MM; LaFontaine ER; Tettelin H J Infect Dis; 2019 Apr; 219(9):1448-1455. PubMed ID: 30496439 [TBL] [Abstract][Full Text] [Related]
9. Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis. Ruckdeschel EA; Brauer AL; Johnson A; Murphy TF Vaccine; 2009 Nov; 27(50):7065-72. PubMed ID: 19786139 [TBL] [Abstract][Full Text] [Related]
10. Use of Moraxella catarrhalis lipooligosaccharide mutants to identify specific oligosaccharide epitopes recognized by human serum antibodies. Schwingel JM; Edwards KJ; Cox AD; Masoud H; Richards JC; St Michael F; Tekwe CD; Sethi S; Murphy TF; Campagnari AA Infect Immun; 2009 Oct; 77(10):4548-58. PubMed ID: 19651870 [TBL] [Abstract][Full Text] [Related]
11. Moraxella catarrhalis uses a twin-arginine translocation system to secrete the β-lactamase BRO-2. Balder R; Shaffer TL; Lafontaine ER BMC Microbiol; 2013 Jun; 13():140. PubMed ID: 23782650 [TBL] [Abstract][Full Text] [Related]
12. Distribution of genes encoding virulence factors ompB2, ompCD, ompE, β-lactamase and serotype in pathogenic and colonizing strains of Moraxella catarrhalis. Mitov IG; Gergova RT; Ouzounova-Raykova VV Arch Med Res; 2010 Oct; 41(7):530-5. PubMed ID: 21167392 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the immunological responses to transferrin and lactoferrin receptor proteins from Moraxella catarrhalis. Yu RH; Bonnah RA; Ainsworth S; Schryvers AB Infect Immun; 1999 Aug; 67(8):3793-9. PubMed ID: 10417140 [TBL] [Abstract][Full Text] [Related]
14. Substrate binding protein SBP2 of a putative ABC transporter as a novel vaccine antigen of Moraxella catarrhalis. Otsuka T; Kirkham C; Johnson A; Jones MM; Murphy TF Infect Immun; 2014 Aug; 82(8):3503-12. PubMed ID: 24914218 [TBL] [Abstract][Full Text] [Related]
16. A Cation-Binding Surface Protein as a Vaccine Antigen To Prevent Moraxella catarrhalis Otitis Media and Infections in Chronic Obstructive Pulmonary Disease. Murphy TF; Brauer AL; Johnson A; Wilding GE; Koszelak-Rosenblum M; Malkowski MG Clin Vaccine Immunol; 2017 Sep; 24(9):. PubMed ID: 28659326 [No Abstract] [Full Text] [Related]
17. Synchrony in serum antibody response to conserved proteins of Ren D; Bajorski P; Murphy TF; Lafontaine ER; Pichichero ME Hum Vaccin Immunother; 2020 Dec; 16(12):3194-3200. PubMed ID: 32401688 [TBL] [Abstract][Full Text] [Related]
19. The transferrin binding protein B of Moraxella catarrhalis elicits bactericidal antibodies and is a potential vaccine antigen. Myers LE; Yang YP; Du RP; Wang Q; Harkness RE; Schryvers AB; Klein MH; Loosmore SM Infect Immun; 1998 Sep; 66(9):4183-92. PubMed ID: 9712766 [TBL] [Abstract][Full Text] [Related]
20. Immunological characterisation of truncated lipooligosaccharide-outer membrane protein based conjugate vaccine against Moraxella catarrhalis and nontypeable Haemophilus influenzae. Singh S; Wilson JC; Cripps AW; Massa H; Ozberk V; Grice ID; Peak IR Vaccine; 2020 Jan; 38(2):309-317. PubMed ID: 31668366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]